Co-Author
This page shows the publications co-authored by Mark Daly and Eric Minikel.
Connection Strength
1.370
-
Author Correction: Evaluating drug targets through human loss-of-function genetic variation. Nature. 2021 Feb; 590(7846):E56.
Score: 0.230
-
Evaluating drug targets through human loss-of-function genetic variation. Nature. 2020 05; 581(7809):459-464.
Score: 0.219
-
Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet. 2019 May; 15(5):e1008190.
Score: 0.204
-
Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet. 2018 05; 14(5):e1007329.
Score: 0.191
-
Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016 Jan 20; 8(322):322ra9.
Score: 0.162
-
Addendum: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2021 09; 597(7874):E3-E4.
Score: 0.060
-
Author Correction: The effect of LRRK2 loss-of-function variants in humans. Nat Med. 2021 Feb; 27(2):355.
Score: 0.057
-
Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2021 Feb; 590(7846):E53.
Score: 0.057
-
The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020 05; 581(7809):434-443.
Score: 0.055
-
The effect of LRRK2 loss-of-function variants in humans. Nat Med. 2020 06; 26(6):869-877.
Score: 0.055
-
Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016 08 18; 536(7616):285-91.
Score: 0.042
-
Human genomics. Effect of predicted protein-truncating genetic variants on the human transcriptome. Science. 2015 May 08; 348(6235):666-9.
Score: 0.039
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.